Please look for the term you need to know by scrolling down the page.
Cannabinoid receptor type 1 (CB1) is a G protein-coupled cannabinoid receptor located primarily in the central and peripheral nervous system. It is activated by the endocannabinoid neurotransmitters (anandamide and 2-arachidonoyl glyceride); by plant cannabinoids (e.g. Tetrahydrocannabinol); or by synthetic analogues of THC (e.g. dronabinol).
Cannabinoid receptor type 2 (CB2), also, is a G protein-coupled receptor from the cannabinoid receptor family. Cannabinoid receptor type 2 is closely related to cannabinoid receptor type 1.
Read more about CB1 and CB2.
Cannabinoid receptor type 1 (CB1) is a G protein-coupled cannabinoid receptor located primarily in the central and peripheral nervous system. It is activated by the endocannabinoid neurotransmitters (anandamide and 2-arachidonoyl glyceride); by plant cannabinoids (e.g. Tetrahydrocannabinol); or by synthetic analogues of THC (e.g. dronabinol).
Cannabinoid receptor type 2 (CB2), also, is a G protein-coupled receptor from the cannabinoid receptor family. Cannabinoid receptor type 2 is closely related to cannabinoid receptor type 1.
Read more about CB1 and CB2.
EGF.
Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation and differentiation, by binding to its receptor, epidermal growth receptor. EGF and its receptor were discovered by Stanley Cohen of Vanderbilt University.Source: Wikipedia.
EGFR.
Epidermal growth factor receptor (EGFR) is the cell-surface receptor for members of the epidermal growth factor family of extracellular protein ligands. It is activated by binding of its ligands, including EGF and transforming growth factor α (TGFα).
Source: Wikipedia.
No comments :
Post a Comment